These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24864536)

  • 21. Managing Agitation Associated with Schizophrenia and Bipolar Disorder in the Emergency Setting.
    Zeller SL; Citrome L
    West J Emerg Med; 2016 Mar; 17(2):165-72. PubMed ID: 26973742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review.
    de Berardis D; Fornaro M; Orsolini L; Iasevoli F; Tomasetti C; de Bartolomeis A; Serroni N; Valchera A; Carano A; Vellante F; Marini S; Piersanti M; Perna G; Martinotti G; Di Giannantonio M
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inhaled loxapine: A novel treatment for agitation in psychotic disorders].
    Siwek M
    Psychiatr Pol; 2014; 48(5):917-30. PubMed ID: 25639013
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Older and Newer Strategies for the Pharmacological Management of Agitation in Patients with Bipolar Disorder or Schizophrenia.
    Amodeo G; Fagiolini A; Sachs G; Erfurth A
    CNS Neurol Disord Drug Targets; 2017; 16(8):885-890. PubMed ID: 28933260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhaled loxapine for agitation in patients with personality disorder: an initial approach.
    Patrizi B; Navarro-Haro MV; Gasol M
    Eur Neuropsychopharmacol; 2019 Jan; 29(1):122-126. PubMed ID: 30497838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhaled loxapine (Adasuve) for acute agitation.
    Med Lett Drugs Ther; 2014 Apr; 56(1440):31-2. PubMed ID: 24736249
    [No Abstract]   [Full Text] [Related]  

  • 27. Intramuscular aripiprazole in the control of agitation.
    Currier GW; Citrome LL; Zimbroff DL; Oren D; Manos G; McQuade R; Pikalov AA; Crandall DT
    J Psychiatr Pract; 2007 May; 13(3):159-69. PubMed ID: 17522559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical perspectives on atypical antipsychotics for treatment of agitation.
    Caine ED
    J Clin Psychiatry; 2006; 67 Suppl 10():22-31. PubMed ID: 16965192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhaled loxapine for acute agitation in a psychiatric emergency service.
    Ruch T; Nuss S; Yeruva RR; Gao Y; Tegin G; Terrell C; El-Mallakh RS
    Ann Clin Psychiatry; 2021 Aug; 33(3):162-167. PubMed ID: 34398731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fifty years of experience with loxapine for the rapid non-coercive tranquilization of acute behavioral disturbances in schizophrenia patients, and beyond.
    Nuss P; Corruble E; Baloche E; P Garay R; Llorca PM
    Expert Rev Neurother; 2022 Aug; 22(8):639-653. PubMed ID: 35913401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inhaled loxapine for emergency treatment of agitated patients with borderline personality disorder : A series of five cases].
    Krüger TH; Wollmer MA; Negt P; Frieling H; Jung S; Kahl KG
    Nervenarzt; 2016 Nov; 87(11):1222-1226. PubMed ID: 26597272
    [No Abstract]   [Full Text] [Related]  

  • 32. Patient preferences for medicine administration for acute agitation: results from an internet-based survey of patients diagnosed with bipolar disorder or schizophrenia in two Nordic countries.
    Jørgensen TR; Emborg C; Dahlen K; Bøgelund M; Carlborg A
    Psychol Health Med; 2018 Jan; 23(1):30-38. PubMed ID: 28475360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled Loxapine for Acute Treatment of Agitation in Patients With Borderline Personality Disorder: A Case Series.
    Kahl KG; Negt P; Wollmer A; Jung S; Kruger TH
    J Clin Psychopharmacol; 2015 Dec; 35(6):741-3. PubMed ID: 26448403
    [No Abstract]   [Full Text] [Related]  

  • 34. Study Enrollment When "Preconsent" Is Utilized for a Randomized Clinical Trial of Two Treatments for Acute Agitation in the Emergency Department.
    Cole JB; Klein LR; Mullinax SZ; Nordstrom KD; Driver BE; Wilson MP
    Acad Emerg Med; 2019 May; 26(5):559-566. PubMed ID: 30548977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Agitation in schizophrenia: origins and evidence-based treatment.
    Citrome L
    Curr Opin Psychiatry; 2021 May; 34(3):216-221. PubMed ID: 33395103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Agitation in Individuals With Bipolar Disorder or Schizophrenia: Lessons Learned for Clinical Psychiatry and Psychiatric Drug Development.
    Preskorn SH
    J Psychiatr Pract; 2022 Jul; 28(4):319-323. PubMed ID: 35797688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of severe agitation with olanzapine in 166 patients with schizophrenia, schizoaffective, or bipolar I disorder.
    Lambert M; Huber CG; Naber D; Schacht A; Wagner TT; Hundemer HP; Karow A; Schimmelmann BG
    Pharmacopsychiatry; 2008 Sep; 41(5):182-9. PubMed ID: 18763220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine.
    Lesem MD; Tran-Johnson TK; Riesenberg RA; Feifel D; Allen MH; Fishman R; Spyker DA; Kehne JH; Cassella JV
    Br J Psychiatry; 2011 Jan; 198(1):51-8. PubMed ID: 21200077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The benefits of an active control arm.
    Shepherd AR
    Br J Psychiatry; 2011 Apr; 198(4):327. PubMed ID: 21972288
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhaled Loxapine for Agitation in Intoxicated Patients: A Case Series.
    Roncero C; Ros-Cucurull E; Palma-Álvarez RF; Abad AC; Fadeuilhe C; Casas M; Grau-López L
    Clin Neuropharmacol; 2017; 40(6):281-285. PubMed ID: 29045249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.